William Tilmouth wins Australia’s highest human rights award and condemns continuing Indigenous policies
Posted on 17 Dec 2025
The founding chair of the ambitious systems-change not-for-profit organisation Children’s Ground,…
Posted on 28 Jan 2025
By Greg Thom, journalist, Institute of Community Directors Australia
The announcement of a new multi-million-dollar children’s medical research facility has been hailed as a shining example of the ability of targeted philanthropy to make a difference in people’s lives.
The Children’s Centre for Transplantation and Research at the Children’s Hospital at Westmead (CHW) in Sydney will focus on improving the lives of children requiring organ transplants.
The Centre will bring together world-leading research to improve the effectiveness of life-saving transplants and could help some children avoid the need for transplant surgery altogether.
The state-of-the-art facility has been made possible by a $3 million donation to the Sydney Children’s Hospital Foundation (SCHF) by the James Fairfax Foundation.
SCHF CEO Kristina Keneally said philanthropy had helped fund advances in research and technology that have improved the lives of sick children battling life-limiting medical conditions.
“Nonetheless, they still need our help to manage chronic and complex ongoing conditions,” she said.
“Philanthropy has the power to supercharge the care that these children receive. It accelerates research and paediatric health outcomes and delivers breakthroughs, milestones, turning points and world firsts.”
Edward Simpson, chair of the James Fairfax Foundation, said he believed the Foundation had a responsibility to support “transformative” projects such as the Children’s Centre for Transplantation and Research.
“This Centre has the potential to dramatically advance the health and wellbeing of unwell children facing life-threatening conditions,” he said.
“By investing in cutting-edge research and technology, we’re proud to give these children and their families new hope and longer lives.
“We hope our generosity inspires other organisations to join us in supporting this groundbreaking initiative.”
Keneally said the Centre would need an additional $1.77 million philanthropic contribution for its initial five years of development and ongoing operation.
“On behalf of all the children requiring a transplant each year, we’re so thankful for the James Fairfax Foundation’s generosity in getting us started, but there is still more work to be done, and more support needed.”
“Philanthropy has the power to supercharge the care that these children receive. It accelerates research and paediatric health outcomes and delivers breakthroughs, milestones, turning points and world firsts.”
Opening new medical frontiers
Professor Gordon Thomas, paediatric transplant surgeon at CHW, said organ transplantation was a vital component of healthcare for children with serious conditions.
However, a transplant, in its current form, is a temporary fix, not a cure.
“Transplants are highly invasive, can have long wait times and, at present, means a lifetime of immuno-suppressive drugs,” said Professor Thomas.
It is hoped the Foundation's donation will help the Centre to become a world leader in trialling potential therapies using machine perfusion.
A perfusion machine enables donated organs to live outside the body, and the Centre will use it to research ways to decrease the possibility of rejection of a donor organ.

The goal will be to use this same research to genetically repair organs that are not working properly, without the need for a transplant.
Professor Ian Alexander, head of the Gene Therapy Research Unit at CHW, said the hospital was collaborating with the Children’s Medical Research Institute and Royal Prince Alfred Hospital to carry out preliminary work involving adult organs on this type of machine.
He said the team had recently become the first medical researchers on the planet to test gene transfer technology in this way.
“In this proposed new facility, where organs can be maintained on these sophisticated pieces of equipment, we can actually go in and test whether our gene repair technology and experimental therapies work in human tissue,” said Professor Alexander.
“This, in turn, dramatically increases the likelihood of therapeutic success when trialled in children.”
Posted on 17 Dec 2025
The founding chair of the ambitious systems-change not-for-profit organisation Children’s Ground,…
Posted on 17 Dec 2025
As we head into the holiday period, the number of Australians battling homelessness has hit crisis…
Posted on 17 Dec 2025
Posturing by the US president about Europe's immigration policies, even warnings of future…
Posted on 17 Dec 2025
For this final Community Advocate edition of the year, we reviewed a whole year’s worth of stories…
Posted on 16 Dec 2025
Lex Lynch spent more than two decades in the climate change and renewables field before last year…
Posted on 16 Dec 2025
As Australia prepares to welcome its one millionth refugee, human rights advocate and former…
Posted on 11 Dec 2025
Community Directors trainer Jon Staley knows from first-hand experience the cost of ignoring…
Posted on 10 Dec 2025
Adele Stowe-Lindner, Executive Director, Community Directors The Institute of Community Directors…
Posted on 10 Dec 2025
The Australia Institute has called on the federal government to force Australian businesses to be…
Posted on 10 Dec 2025
Economic empowerment is essential to enabling recovery, restoring agency and preventing future…
Posted on 10 Dec 2025
A long-time advocate for rough sleepers in northern New South Wales has been named her state’s…
Posted on 10 Dec 2025
What a year 2025 has been, particularly at a national level where the Parliament and politics as we…